{"id":172461,"date":"2025-11-18T03:46:26","date_gmt":"2025-11-18T08:46:26","guid":{"rendered":"https:\/\/44.250.171.167\/?p=172461"},"modified":"2025-11-18T03:46:26","modified_gmt":"2025-11-18T08:46:26","slug":"concord-biotech-q2-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/concord-biotech-q2-fy26-earnings-results\/","title":{"rendered":"Concord Biotech\u00a0Q2 FY26 Earnings Results"},"content":{"rendered":"<p>Concord Biotech Limited, an India-based R&amp;D-driven biopharma company specializing in fermentation-based APIs for immunosuppressants and oncology, reported a decline in financial performance for Q2FY26.<\/p>\n<h2>Financial Highlights:<\/h2>\n<ul>\n<li>Revenues declined 20.32% year-on-year to \u20b9247 crore from \u20b9310 crore.<\/li>\n<li>Total expenses decreased 6.35% to \u20b9177 crore from \u20b9189 crore.<\/li>\n<li>Consolidated net <a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/ae698aba-dfb5-445e-a99f-f63c2f3bc44a.pdf\" target=\"_blank\" rel=\"noopener\">profit<\/a> dropped 34.38% to \u20b963 crore from \u20b996 crore.<\/li>\n<li>Earnings per share fell 33.55% to \u20b96.08 from \u20b99.15.<\/li>\n<\/ul>\n<p>The profit decline was primarily due to lower revenues despite cost reductions. The company is focusing on strengthening its product pipeline and operational efficiencies.<\/p>\n<h2>Outlook:<\/h2>\n<p>Concord Biotech aims to enhance R&amp;D, expand its product portfolio, and improve manufacturing capabilities to drive future growth. It is well-positioned to benefit from growing demand in immunosuppressants and oncology segments.<\/p>\n<p>Explore the company\u2019s past earnings and latest concall transcripts, <a href=\"https:\/\/44.250.171.167\/symbol\/concordbio\/\">click here<\/a> to visit the AlphaStreet India News Channel.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-172462\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/C-4.png\" alt=\"Q2 FY26\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/C-4.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/C-4-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/C-4-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/C-4-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/C-4-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Concord Biotech Limited, an India-based R&amp;D-driven biopharma company specializing in fermentation-based APIs for immunosuppressants and oncology, reported a decline in financial performance for Q2FY26. Financial Highlights: Revenues declined 20.32% year-on-year to \u20b9247 crore from \u20b9310 crore. Total expenses decreased 6.35% to \u20b9177 crore from \u20b9189 crore. Consolidated net profit dropped 34.38% to \u20b963 crore from [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":172462,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10304,11333],"class_list":["post-172461","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-api","tag-oncology"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/C-4.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":171070,"url":"https:\/\/alphastreet.com\/india\/concord-biotech-q1-fy26-earnings-results\/","url_meta":{"origin":172461,"position":0},"title":"Concord Biotech Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"September 9, 2025","format":false,"excerpt":"Concord Biotech Limited, incorporated in 1984, is an India-based R&D-driven biopharma company specializing in the manufacture of fermentation-based active pharmaceutical ingredients (APIs) primarily for immunosuppressants and oncology. Presenting below its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results: Revenue: \u20b9204 crore, down 5.56% year-on-year YoY from \u20b9216 crore Total Expenses:\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"CONCORDBIO Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CONCOR.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CONCOR.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CONCOR.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CONCOR.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CONCOR.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CONCOR.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166037,"url":"https:\/\/alphastreet.com\/india\/concord-biotech-ltd-q2fy25-19-rise-in-profits\/","url_meta":{"origin":172461,"position":1},"title":"Concord Biotech Ltd Q2FY25; 19% rise in Profits","author":"Divyansh_Kasana","date":"December 12, 2024","format":false,"excerpt":"Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology. Financial Results: Concord Biotech Ltd reported Revenues for Q2FY25 of \u20b9310.00 Crores up from \u20b9262.00 Crore year on year, a rise of 18.32%. Total Expenses for Q2FY25 of \u20b9189.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HT-2.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HT-2.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HT-2.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HT-2.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HT-2.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/HT-2.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166453,"url":"https:\/\/alphastreet.com\/india\/concord-biotech-ltd-q3fy25-33-rise-in-profits\/","url_meta":{"origin":172461,"position":2},"title":"Concord Biotech Ltd Q3FY25; 33% rise in Profits","author":"Divyansh_Kasana","date":"January 21, 2025","format":false,"excerpt":"Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology. Financial Results: Concord Biotech Ltd reported Revenues for Q3FY25 of \u20b9237.00 Crores up from \u20b9241.00 Crore year on year, a rise of 30.22%. Total Expenses for Q3FY25 of \u20b9141.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ-2.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ-2.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ-2.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ-2.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ-2.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ-2.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168963,"url":"https:\/\/alphastreet.com\/india\/concord-biotech-ltd-q4fy25-47-rise-in-profits\/","url_meta":{"origin":172461,"position":3},"title":"Concord Biotech Ltd Q4FY25; 47% rise in Profits","author":"Divyansh_Kasana","date":"July 1, 2025","format":false,"excerpt":"Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology. Financial Results: Concord Biotech Ltd reported Revenues for Q4FY25 of \u20b9430.00 Crores up from \u20b9319.00 Crore year on year, a rise of 34.8%. Total Expenses for Q4FY25 of \u20b9256.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":144681,"url":"https:\/\/alphastreet.com\/india\/rossari-biotech-ltd-q4fy23-results-out-net-profit-soars-by-21\/","url_meta":{"origin":172461,"position":4},"title":"Rossari Biotech Ltd Q4FY23 results out, Net Profit soars by 21%","author":"Chirag Gupta","date":"May 1, 2023","format":false,"excerpt":"Started in 2003, Rossari Biotech is among the largest manufacturers of textile specialty chemicals in India. Their 3 main product categories are:- Home, personal care & performance chemicals, Textile specialty chemical and Animal health and nutrition. The company has two R&D facilities, one at Silvassa manufacturing facility and a research\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":157236,"url":"https:\/\/alphastreet.com\/india\/shilpa-medicare-ltd-q2fy24-19-rise-in-revenue\/","url_meta":{"origin":172461,"position":5},"title":"Shilpa Medicare Ltd Q2FY24; 19% rise in Revenue","author":"Chirag Gupta","date":"December 11, 2023","format":false,"excerpt":"Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech products, and Specialty chemicals using sophisticated technology. SML is one of the worlds leading suppliers of Oncology\/ Non Oncology API's and intermediates. Financial Results: Shilpa Medicare Ltd reported\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/172461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=172461"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/172461\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/172462"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=172461"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=172461"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=172461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}